Eagle,
Yes, and the shorts know that too. The irony, to be absolutely clear, is the short's daily bashing is because they actually want to BUY NWBO shares, lots of it. All of it if they can, particularly under $5/share, before the institutional investors come in. That is why they constantly export their misery and their manufactured feeling of hopelessness, so that "even with approval" the price will stay in the $5 to $10/share range.
In reality there is much to be optimistic about. We already won on the intrinsic value of NWBO (Sawston, patents) and DCVax-L (clinical trials, support by oncologists). The stock price is at a ridiculously and manipulated low price now. Therefore it is only a matter of time. The stock price will eventually rise to meet up with its long separated partner and marathon runner, intrinsic value.
Because UK approval is 2 to 4 months away, I believe new money buyers are already here and watching. Their #1 goal is to front run and surprise. A matter of time. Also normally 70% of ownership is institutional. We have 0% now. There is an eventuality. That will be reflected in a high price-to-sales multiple in the first couple of years after initial sales. So we retail investors all just have to stay disciplined. All IMHO.
Market Data 
Markets 
AI
